港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

晶泰控股

7.605

+0.2303.12%

成交量：4,592.90萬

成交額：3.46億

市值：327.24億

市盈率：253.50

高：7.675

開：7.400

低：7.300

收：7.375

52周最高：15.120

52周最低：6.300

股本：43.03億

香港流通股本：43.03億

量比：0.66

換手率：1.07%

股息：- -

股息率：- -

每股收益(LYR):0.030

淨資產收益率：-2.06%

總資產收益率：-5.20%

市淨率：3.12

市盈率(LYR):253.50

市銷率: 41.29

資料載入中...

總覽公司新聞資訊公告

AI4S迎來「結算周期」：誰在率先跑通「規模化量產」閉環？

異動解讀｜晶泰控股盤中下跌5.59%，中期由盈轉虧疊加前日板塊大漲後獲利回吐

直擊業績會丨晶泰控股上半年由盈轉虧：加碼自研管線投入，AI製藥「賣水人」要親自下場「淘金」？

每日经济新闻

晶泰科技(02228)2026中期業績解碼：AI4S商業化高速突破，多模態管線加速兑現

《信而有證》創新藥股再落鑊阿里日內放榜快手績後挫逾1成博反彈吼快手購16413

阿斯达克财经

晶泰控股(02228)股價顯著上升13.97%，現價港幣$8.24

阿斯达克财经

mRNA領域重大突破！創新藥概念股飆升，雲頂新耀飆升55%，晶泰控股、金斯瑞大升逾12%

港股創新藥概念股集體走強，中國生物製藥升逾20%，石藥集團升逾16%

老虎资讯综合

異動解讀｜晶泰控股盤中上漲9.96%，中期業績剔除高基數後主業增長73.8%獲市場認可

晶泰控股(02228)發布中期業績收入3.94億元研發開支按年增加66.05%

晶泰控股（02228）發布2026年中報：營收3.94億元，按年降23.9%，研發投入增長66%

異動解讀｜晶泰控股盤中下跌5.62%，中期業績披露前夕市場搶跑拋壓集中釋放

再獲"醫藥界諾貝爾獎"提名！晶泰科技孵化企業萊芒生物、默達生物共同入圍2026蓋倫獎

創新藥概念集體回調康方生物（09926）跌6.85%、維亞生物（01873）跌6.33%

異動解讀｜晶泰控股盤中下跌5.01%，板塊集體回調疊加業績窗口期承壓

晶泰控股(02228)股價下跌5.006%，現價港幣$7.78

阿斯达克财经

【券商聚焦】中信建投：AI製藥大有可為，產業鏈有望持續受益

財報前瞻｜晶泰控股本季度營收暫無一致預測，機構觀點尚不明確

創新藥概念繼續走強金斯瑞生物科技（01548）漲6.87% 機構指中國創新藥全球地位持續提升

異動解讀 | 晶泰控股盤中大漲5.04%，AI平台發布及大行唱好持續催化

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/02228/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02228","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":7.605,"timestamp":1787645294004,"preClose":7.375,"halted":0,"volume":45928955,"delay":0,"changeRate":0.031186440677966158,"floatShares":4303000000,"shares":4303000000,"eps":0.03,"marketStatus":"未開盤","change":0.23,"latestTime":"08-25 16:08:14","open":7.4,"high":7.675,"low":7.3,"amount":346333534,"amplitude":0.050847,"askPrice":7.605,"askSize":38000,"bidPrice":7.6,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":-0.056,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":0,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":7.375,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":0.662789,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","floatShares":4303000000,"roa":"-5.20%","roe":"-2.06%","lyrEps":0.03,"volumeRatio":0.662789,"shares":4303000000,"dividePrice":0,"high":7.675,"amplitude":0.050847,"preClose":7.375,"low":7.3,"week52Low":6.3,"pbRate":"3.12","psRate":"41.29","week52High":15.12,"institutionHeld":0,"latestPrice":7.605,"committee":-0.617021,"eps":0.03,"divideRate":0,"volume":45928955,"delay":0,"ttmEps":-0.056,"open":7.4,"prevYearClose":9.46,"prevWeekClose":7.71,"prevMonthClose":6.84,"prevQuarterClose":7.65,"fiveDayClose":7.5,"twentyDayClose":7.12,"sixtyDayClose":8.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02228\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-03-25","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774402200000,"name":null,"time":"","dateTimestamp":1774368000000,"actualEps":null},{"date":"2025-08-27","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756258200000,"name":null,"time":"","dateTimestamp":1756224000000,"actualEps":null},{"date":"2025-03-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02228\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02228\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.3333,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":6,"updateTime":1784822400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02228\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02228","date":"2026-08-24","current":-135.803571,"percent":0.265306,"low":-297.4207,"twenty":-190.073971,"median":-9.716174,"eighty":-5.125587,"high":312.892106,"avg":-18.367173,"sd":151.693145,"marketCap":31737366737},"quantilePoints":[{"date":"2024-06-14","current":-8.922014,"twenty":-9.439723,"median":-9.245582,"eighty":-9.051441,"marketCap":18396572909},{"date":"2024-06-21","current":-8.857946,"twenty":-8.9092,"median":-8.775161,"eighty":-8.737522,"marketCap":18226234271},{"date":"2024-06-28","current":-8.745676,"twenty":-8.918198,"median":-8.816527,"eighty":-8.750223,"marketCap":17987760178},{"date":"2024-07-05","current":-8.747576,"twenty":-8.902934,"median":-8.771787,"eighty":-8.744343,"marketCap":17987760178},{"date":"2024-07-12","current":-9.049063,"twenty":-8.902934,"median":-8.775161,"eighty":-8.741587,"marketCap":18635047002},{"date":"2024-07-19","current":-9.247407,"twenty":-9.172529,"median":-8.857489,"eighty":-8.744343,"marketCap":19043859733},{"date":"2024-07-26","current":-9.575773,"twenty":-9.510189,"median":-8.892407,"eighty":-8.745676,"marketCap":19793349741},{"date":"2024-08-02","current":-9.235042,"twenty":-9.509847,"median":-8.912474,"eighty":-8.745676,"marketCap":19077927461},{"date":"2024-08-09","current":-9.468775,"twenty":-9.510189,"median":-8.974725,"eighty":-8.747576,"marketCap":19691146558},{"date":"2024-08-16","current":-10.464009,"twenty":-9.56947,"median":-9.142341,"eighty":-8.760904,"marketCap":21769277942},{"date":"2024-08-23","current":-10.517808,"twenty":-9.632925,"median":-9.235042,"eighty":-8.768412,"marketCap":21973684308},{"date":"2024-08-30","current":-10.371399,"twenty":-10.303269,"median":-9.325095,"eighty":-8.775161,"marketCap":28923500740},{"date":"2024-09-06","current":-18.461728,"twenty":-10.496901,"median":-9.468775,"eighty":-8.776023,"marketCap":51510404146},{"date":"2024-09-13","current":-17.236995,"twenty":-10.891661,"median":-9.521964,"eighty":-8.857032,"marketCap":47967360474},{"date":"2024-09-20","current":-16.063353,"twenty":-11.51195,"median":-9.559061,"eighty":-8.857763,"marketCap":44969400445},{"date":"2024-09-27","current":-15.483466,"twenty":-14.686278,"median":-9.575773,"eighty":-8.860072,"marketCap":43606691340},{"date":"2024-10-04","current":-13.755671,"twenty":-14.947547,"median":-9.615329,"eighty":-8.879685,"marketCap":38564667654},{"date":"2024-10-10","current":-12.348216,"twenty":-14.780027,"median":-9.846626,"eighty":-8.896618,"marketCap":34408404886},{"date":"2024-10-18","current":-11.446606,"twenty":-14.586898,"median":-10.272952,"eighty":-8.910566,"marketCap":31717054404},{"date":"2024-10-25","current":-12.086709,"twenty":-14.247622,"median":-10.371399,"eighty":-8.935918,"marketCap":33488576240},{"date":"2024-11-01","current":-11.046421,"twenty":-13.547793,"median":-10.507354,"eighty":-8.963954,"marketCap":30626887121},{"date":"2024-11-08","current":-8.233542,"twenty":-13.084166,"median":-10.464009,"eighty":-8.959678,"marketCap":22655038860},{"date":"2024-11-15","current":-6.674421,"twenty":-12.818197,"median":-10.331022,"eighty":-8.873325,"marketCap":18226234271},{"date":"2024-11-22","current":-5.092957,"twenty":-12.605094,"median":-9.956054,"eighty":-8.775506,"marketCap":13899632864},{"date":"2024-11-29","current":-4.071689,"twenty":-12.362191,"median":-9.633447,"eighty":-8.746436,"marketCap":11106079200},{"date":"2024-12-06","current":-6.234627,"twenty":-12.309524,"median":-9.607633,"eighty":-8.729287,"marketCap":16965728349},{"date":"2024-12-13","current":-4.937116,"twenty":-12.241743,"median":-9.572622,"eighty":-8.309283,"marketCap":13422684678},{"date":"2024-12-20","current":-6.992956,"twenty":-12.176011,"median":-9.548971,"eighty":-7.374004,"marketCap":18907588823},{"date":"2024-12-27","current":-7.61626,"twenty":-12.099333,"median":-9.521964,"eighty":-6.992956,"marketCap":20576907476},{"date":"2025-01-03","current":-6.613619,"twenty":-12.089234,"median":-9.489311,"eighty":-6.978437,"marketCap":17885556995},{"date":"2025-01-10","current":-5.450117,"twenty":-12.058756,"median":-9.391379,"eighty":-6.644107,"marketCap":14683190599},{"date":"2025-01-17","current":-5.875315,"twenty":-12.04248,"median":-9.241225,"eighty":-6.25569,"marketCap":15841493338},{"date":"2025-01-24","current":-6.177753,"twenty":-11.949888,"median":-9.172529,"eighty":-6.11967,"marketCap":16761321984},{"date":"2025-01-28","current":-6.498305,"twenty":-11.921589,"median":-9.112153,"eighty":-6.130311,"marketCap":17715218357},{"date":"2025-02-07","current":-7.424154,"twenty":-11.872333,"median":-8.96938,"eighty":-6.148709,"marketCap":20134027017},{"date":"2025-02-14","current":-8.323374,"twenty":-11.760531,"median":-8.922014,"eighty":-6.178085,"marketCap":22518767950},{"date":"2025-02-21","current":-10.607329,"twenty":-11.720414,"median":-8.939394,"eighty":-6.187416,"marketCap":28855365285},{"date":"2025-02-28","current":-8.380735,"twenty":-11.643652,"median":-8.964036,"eighty":-6.222464,"marketCap":22723174315},{"date":"2025-03-07","current":-8.409794,"twenty":-11.556185,"median":-8.912474,"eighty":-6.239893,"marketCap":22893512953},{"date":"2025-03-14","current":-8.131514,"twenty":-11.5122,"median":-8.860603,"eighty":-6.269085,"marketCap":22144022946},{"date":"2025-03-21","current":-7.997044,"twenty":-11.440339,"median":-8.816527,"eighty":-6.340941,"marketCap":21769277942},{"date":"2025-03-28","current":-9.307254,"twenty":-11.391935,"median":-8.776023,"eighty":-6.503525,"marketCap":25284615976},{"date":"2025-04-03","current":-13.220486,"twenty":-11.563082,"median":-8.857032,"eighty":-6.524404,"marketCap":21465794803},{"date":"2025-04-11","current":-11.616184,"twenty":-11.563082,"median":-8.876505,"eighty":-6.613619,"marketCap":18692124688},{"date":"2025-04-17","current":-8.481901,"twenty":-11.535495,"median":-8.876505,"eighty":-6.644107,"marketCap":18290143512},{"date":"2025-04-25","current":-9.200975,"twenty":-11.479403,"median":-8.897671,"eighty":-6.665344,"marketCap":19857870099},{"date":"2025-05-02","current":-9.49742,"twenty":-11.434072,"median":-8.939394,"eighty":-6.691701,"marketCap":20541238098},{"date":"2025-05-09","current":-8.545306,"twenty":-11.391935,"median":-8.912474,"eighty":-6.740034,"marketCap":18611728453},{"date":"2025-05-16","current":-7.908546,"twenty":-11.248155,"median":-8.860603,"eighty":-6.84782,"marketCap":17365586807},{"date":"2025-05-23","current":-8.341266,"twenty":-11.042865,"median":-8.857489,"eighty":-6.934878,"marketCap":18370539747},{"date":"2025-05-30","current":-8.359272,"twenty":-11.017454,"median":-8.801107,"eighty":-7.008251,"marketCap":18491134100},{"date":"2025-06-06","current":-8.60989,"twenty":-10.956499,"median":-8.771787,"eighty":-7.088154,"marketCap":19094105864},{"date":"2025-06-13","current":-11.034423,"twenty":-11.017454,"median":-8.801107,"eighty":-7.190725,"marketCap":24480653624},{"date":"2025-06-20","current":-10.674849,"twenty":-11.017454,"median":-8.857489,"eighty":-7.306284,"marketCap":23636493154},{"date":"2025-06-27","current":-10.445897,"twenty":-10.956499,"median":-8.892407,"eighty":-7.344497,"marketCap":23194313860},{"date":"2025-07-04","current":-9.829906,"twenty":-10.891661,"median":-8.922014,"eighty":-7.419935,"marketCap":21827577862},{"date":"2025-07-11","current":-10.057272,"twenty":-10.877908,"median":-8.960404,"eighty":-7.424154,"marketCap":22309955273},{"date":"2025-07-18","current":-11.044472,"twenty":-10.891661,"median":-8.991768,"eighty":-7.446553,"marketCap":24480653624},{"date":"2025-07-25","current":-11.600754,"twenty":-10.891661,"median":-9.041584,"eighty":-7.524651,"marketCap":25807191505},{"date":"2025-08-01","current":-10.363772,"twenty":-11.018326,"median":-9.112153,"eighty":-7.542967,"marketCap":22912927037},{"date":"2025-08-08","current":-12.886171,"twenty":-11.034423,"median":-9.184965,"eighty":-7.546272,"marketCap":28560882520},{"date":"2025-08-15","current":-16.789867,"twenty":-11.214642,"median":-9.213525,"eighty":-7.606542,"marketCap":37157266289},{"date":"2025-08-22","current":-18.517848,"twenty":-11.446606,"median":-9.246727,"eighty":-7.614904,"marketCap":40852907909},{"date":"2025-08-29","current":-192.489316,"twenty":-11.600754,"median":-9.307254,"eighty":-7.61626,"marketCap":41415288155},{"date":"2025-09-05","current":-213.80174,"twenty":-11.767021,"median":-9.420728,"eighty":-7.685893,"marketCap":45955204407},{"date":"2025-09-12","current":-204.225419,"twenty":-12.040158,"median":-9.491689,"eighty":-7.778357,"marketCap":43975860397},{"date":"2025-09-19","current":-210.969495,"twenty":-12.227129,"median":-9.510018,"eighty":-7.835319,"marketCap":45395824578},{"date":"2025-09-26","current":-243.797394,"twenty":-12.760818,"median":-9.548971,"eighty":-7.865608,"marketCap":52323528613},{"date":"2025-10-03","current":-292.020324,"twenty":-13.170522,"median":-9.56947,"eighty":-7.879637,"marketCap":62822657710},{"date":"2025-10-10","current":-230.752283,"twenty":-13.473827,"median":-9.584146,"eighty":-7.898385,"marketCap":49569658686},{"date":"2025-10-17","current":-224.517278,"twenty":-14.439918,"median":-9.600107,"eighty":-7.946472,"marketCap":48192723723},{"date":"2025-10-24","current":-228.64383,"twenty":-14.683263,"median":-9.632925,"eighty":-7.976689,"marketCap":49096337293},{"date":"2025-10-31","current":-227.302855,"twenty":-15.037482,"median":-9.687573,"eighty":-7.986804,"marketCap":48881191204},{"date":"2025-11-07","current":-224.641911,"twenty":-15.538461,"median":-9.759922,"eighty":-8.024089,"marketCap":48278782158},{"date":"2025-11-14","current":-224.606105,"twenty":-15.942578,"median":-9.829906,"eighty":-8.077422,"marketCap":48407869811},{"date":"2025-11-21","current":-193.151407,"twenty":-16.49847,"median":-9.886762,"eighty":-8.100259,"marketCap":41609253428},{"date":"2025-11-28","current":-199.219037,"twenty":-17.166208,"median":-9.938523,"eighty":-8.106838,"marketCap":43072246827},{"date":"2025-12-05","current":-187.760939,"twenty":-18.514915,"median":-10.001834,"eighty":-8.117649,"marketCap":40664736891},{"date":"2025-12-12","current":-188.405895,"twenty":-19.068562,"median":-10.222616,"eighty":-8.135742,"marketCap":40879894229},{"date":"2025-12-19","current":-193.107159,"twenty":-182.944903,"median":-10.286693,"eighty":-8.147362,"marketCap":41998712387},{"date":"2025-12-24","current":-187.379254,"twenty":-183.750789,"median":-10.358775,"eighty":-8.155277,"marketCap":40879894229},{"date":"2026-01-02","current":-196.271618,"twenty":-186.427584,"median":-10.370179,"eighty":-8.201595,"marketCap":42988436142},{"date":"2026-01-09","current":-245.771901,"twenty":-187.621801,"median":-10.429746,"eighty":-8.229469,"marketCap":53964281882},{"date":"2026-01-16","current":-246.929371,"twenty":-188.372912,"median":-10.482224,"eighty":-8.239136,"marketCap":54394619059},{"date":"2026-01-23","current":-263.592118,"twenty":-190.87121,"median":-10.504599,"eighty":-8.301527,"marketCap":58009451338},{"date":"2026-01-30","current":-235.141136,"twenty":-193.603995,"median":-10.543073,"eighty":-8.322054,"marketCap":51984730872},{"date":"2026-02-06","current":-219.013364,"twenty":-197.532613,"median":-10.601857,"eighty":-8.337688,"marketCap":48542033464},{"date":"2026-02-13","current":-216.411202,"twenty":-199.732866,"median":-10.622843,"eighty":-8.346337,"marketCap":48240797440},{"date":"2026-02-20","current":-217.496685,"twenty":-200.370892,"median":-10.632511,"eighty":-8.349193,"marketCap":48412932311},{"date":"2026-02-27","current":-198.117521,"twenty":-201.706301,"median":-10.683926,"eighty":-8.35629,"marketCap":44582931443},{"date":"2026-03-06","current":-193.944032,"twenty":-200.836274,"median":-10.725072,"eighty":-8.360262,"marketCap":43291919915},{"date":"2026-03-13","current":-182.308277,"twenty":-200.370892,"median":-10.764069,"eighty":-8.367027,"marketCap":40882031729},{"date":"2026-03-20","current":-183.00122,"twenty":-199.750299,"median":-10.801931,"eighty":-8.378249,"marketCap":40882031729},{"date":"2026-03-27","current":294.840625,"twenty":-199.625451,"median":-10.818164,"eighty":-8.367027,"marketCap":41312368905},{"date":"2026-04-02","current":293.430464,"twenty":-199.219037,"median":-10.7806,"eighty":-8.347605,"marketCap":41312368905},{"date":"2026-04-10","current":297.250988,"twenty":-199.099625,"median":-10.751478,"eighty":-8.320734,"marketCap":42173043257},{"date":"2026-04-17","current":308.041066,"twenty":-198.478519,"median":-10.715507,"eighty":-8.190016,"marketCap":43722257091},{"date":"2026-04-24","current":252.239802,"twenty":-197.80739,"median":-10.674849,"eighty":-8.107361,"marketCap":35804053051},{"date":"2026-04-30","current":288.849626,"twenty":-197.566624,"median":-10.632511,"eighty":-8.024089,"marketCap":41011132882},{"date":"2026-05-08","current":276.07071,"twenty":-197.460304,"median":-10.604832,"eighty":-7.893305,"marketCap":39332817895},{"date":"2026-05-15","current":246.426078,"twenty":-196.935057,"median":-10.5706,"eighty":-7.722879,"marketCap":35201581004},{"date":"2026-05-22","current":240.04583,"twenty":-195.928709,"median":-10.515052,"eighty":-7.57038,"marketCap":34211805499},{"date":"2026-05-29","current":247.940056,"twenty":-195.190047,"median":-10.495779,"eighty":-7.462173,"marketCap":35459783310},{"date":"2026-06-05","current":225.046084,"twenty":-194.223092,"median":-10.464009,"eighty":-7.306284,"marketCap":32232254489},{"date":"2026-06-12","current":211.668463,"twenty":-193.859261,"median":-10.392497,"eighty":-6.934878,"marketCap":30295737197},{"date":"2026-06-18","current":198.264169,"twenty":-193.520175,"median":-10.366976,"eighty":-6.674421,"marketCap":28445287340},{"date":"2026-06-26","current":203.45699,"twenty":-193.151407,"median":-10.303269,"eighty":-6.498305,"marketCap":29047759386},{"date":"2026-07-03","current":237.94203,"twenty":-193.116009,"median":-10.242635,"eighty":-6.231586,"marketCap":33996636911},{"date":"2026-07-10","current":238.837525,"twenty":-192.669729,"median":-10.052442,"eighty":-6.138664,"marketCap":34082704347},{"date":"2026-07-17","current":215.754081,"twenty":-192.503527,"median":-9.948544,"eighty":-6.052638,"marketCap":30898209243},{"date":"2026-07-24","current":216.306463,"twenty":-192.12725,"median":-9.924156,"eighty":-5.880689,"marketCap":30984276679},{"date":"2026-07-31","current":205.10151,"twenty":-191.655571,"median":-9.850457,"eighty":-5.716216,"marketCap":29435062845},{"date":"2026-08-07","current":225.952556,"twenty":-190.908483,"median":-9.792682,"eighty":-5.612688,"marketCap":32490456795},{"date":"2026-08-14","current":234.78321,"twenty":-190.506231,"median":-9.716174,"eighty":-5.442004,"marketCap":33802985182},{"date":"2026-08-21","current":-134.888122,"twenty":-190.16977,"median":-9.693656,"eighty":-5.11743,"marketCap":33178996277},{"date":"2026-08-24","current":-129.073687,"twenty":-190.073971,"median":-9.716174,"eighty":-5.125587,"marketCap":31737366737}],"updateTime":1787656919672},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02228\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662786349","title":"AI4S迎來「結算周期」：誰在率先跑通 「規模化量產」閉環？","url":"https://stock-news.laohu8.com/highlight/detail?id=2662786349","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662786349?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 13:38","pubTimestamp":1787636333,"startTime":"0","endTime":"0","summary":"AI4S智慧解决方案收入达到1.94亿元，同比增速高达136.4%","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6282098","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02228","QTOC","BK6092","BK1141","CHAT","VTHR","BK6511","5RE.SI","AGIX","BK1617","ARTY","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134683447","title":"異動解讀｜晶泰控股盤中下跌5.59%，中期由盈轉虧疊加前日板塊大漲後獲利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1134683447","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134683447?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 09:43","pubTimestamp":1787276602,"startTime":"0","endTime":"0","summary":"8月21日，晶泰控股盘中下跌5.59%，报7.595港元，成交额9982.35万港元。研发开支3.68亿元，同比增长66%，主因加大自主实验室及在研管线投入。此外，公司股价前一交易日受mRNA突破消息带动板块联动大涨11.27%，短期获利盘集中回吐形成抛压。晶泰控股是一家AI驱动的药物及材料科学研发平台公司，主要从事药物发现解决方案及智能自动化解决方案业务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"晶泰控股由盈转亏，股价承压回落","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661309236","title":"直擊業績會丨晶泰控股上半年由盈轉虧：加碼自研管線投入，AI製藥「賣水人」要親自下場「淘金」？","url":"https://stock-news.laohu8.com/highlight/detail?id=2661309236","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661309236?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 00:13","pubTimestamp":1787242410,"startTime":"0","endTime":"0","summary":"8月19日晚间，港股AI制药龙头晶泰控股（02228.HK）交出了2026年中期“成绩单”。报告期内，公司实现营业收入3.94亿元，同比下降约23.9%；期内净亏损为2.25亿元，而去年同期净利润为7560.9万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608213848232569.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608213848232569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QTOC","AIPO","ARTY","BK1191","BK1617","AGIX","02228","01477","BK1574","VTHR","BK1141","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660340615","title":"晶泰科技(02228)2026中期業績解碼：AI4S商業化高速突破，多模態管線加速兑現","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340615?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 14:19","pubTimestamp":1787206774,"startTime":"0","endTime":"0","summary":"8月19日，晶泰科技发布2026年中期业绩公告。这是晶泰科技从“AI制药服务商”升级为“贯通数字研发与物理实验的AI4S平台”的第一份中报。截至2026年6月30日，公司现金余额合计86.71亿元，充沛的资金储备为持续研发投入提供保障，巩固公司在AI4S领域领先地位。公司搭建行业领先的全流程AI自主决策实验合成能力，相关业务实现高速增长。相较之下，晶泰科技同时拥有真实落地业务场景、确认收入以及高速迭代的管线储备。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1617","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403292","title":"《信而有證》創新藥股再落鑊 阿里日內放榜 快手績後挫逾1成 博反彈吼快手購16413","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403292","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403292?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 13:20","pubTimestamp":1787203200,"startTime":"0","endTime":"0","summary":"惟期内对AI投入增加而导致研发开支大幅增加34.7%至45.8亿元。快手股价早段急挫逾11%，低位见33.2元，已迫近历史最低位30.6元，14天RSI已跌至22。如认为快手超卖反弹在即，可留意目前市面上最贴价的认购证选择，快手认购证，行使价42.88元，27年2月到期，实际杠杆约4倍；相反，追沽可留意快手认沽证 ，行使价32.5元，10月底到期，实际杠杆约5倍。其次季业绩大胜预期，且AI相关收入增长6成。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260417085517124_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260417085517124_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1539539/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1539539/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1615","03419","LU0348766576.USD","LU0417516738.SGD","LU0588546209.SGD","LU0593848301.USD","LU0052756011.USD","LU2097828714.EUR","LU2399975544.HKD","03037","LU2097828631.EUR","LU0791590937.USD","LU2097828805.USD","IE0034224299.USD","LU0307460666.USD","02228","03115","IE0032431581.USD","KURE","BK4568","LU2097828474.EUR","09926","LU0572944931.SGD","01024","BK4585","LU0359201612.USD","BK4551","IE00B0JY6N72.USD","83115","LU1188198961.HKD","LU2476274720.SGD","LU0791591158.USD","BK1574","LU0051755006.USD","LU1235295612.USD","LU0348783233.USD","BK1610","LU1366334651.USD","LU1267930227.SGD","TCHI","LU1961090484.USD","LGHT","LU0211977185.USD","BK4139","LU0561508036.HKD","BK1591","LU1770034418.SGD","BK1617","BK4588","LU0417516571.SGD","IDNA","BK1589","BK4501","LU0862451837.USD","LU0029875118.USD","LU0359201885.HKD","LU0348735423.USD","IE00BPRC5H50.USD","LU0672654166.SGD","LU0049112450.USD","HK0000320223.HKD","IE00B5MMRT66.SGD","LU0048580855.USD","LU1046422090.SGD","LU0540923850.HKD","GNOM","LU0634319403.HKD","LU0359202008.SGD","MHImain","LU0210526637.USD","WDNA","HK0000306701.USD","07300","MRNA","HSI","SOCL","BK4534","DRGN","BK1095","BK1526","LU0572939691.SGD","IE00B543WZ88.USD","LU2242644610.SGD","BK1608","BK1607","LNVGY","LU1719994722.HKD","BK1590","IE00BZ08YR35.GBP","09115","02800","LU0320764755.SGD","BK4532","LU2476274308.USD","SBHMY","MRNX","LU1794554557.SGD","LU0327786744.USD","LU0244354667.USD","80992","81024","LU0128522157.USD","LU0456827905.SGD","IE00BZ08YT58.USD","BK1141","BK1193","01177","LU0310800965.SGD","LU0370786039.SGD","LU1251922891.USD","LU0348767384.USD","LU2097828557.USD","07200","LU0348825331.USD","LU2488822045.USD","HK0000165453.HKD","BK1191","HK0000320264.USD","IE0003895053.USD","BK1161","LU0463099449.HKD","LU0572940350.SGD","00992","07500","LU1303224171.USD","BK4533","LU0543330483.HKD","LU1023057109.AUD","LU0417516902.SGD","82800","LU0264606111.USD","LU0128525689.USD","LU0348784397.USD","LU0862451753.SGD","LU1720050803.USD","LU1366334578.USD","LU2778985437.USD","LU0348827113.USD","BK1521","LU0140636845.USD","513600","BK1515","LU0890818403.SGD","BK4548","BK1575","IE00BZ08YS42.EUR","LU0326950275.SGD","MRNY","HSTECH","HK0000306685.HKD","02833","HHImain","MCHmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660066477","title":"晶泰控股(02228)股價顯著上升13.97%，現價港幣$8.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2660066477","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660066477?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:33","pubTimestamp":1787193180,"startTime":"0","endTime":"0","summary":"[上升股]晶泰控股(02228) 股价在上午10:33比前收市价显著上升13.97%，现股价为港币$8.24。至目前为止，今日最高价为$8.24，而最低价为$7.8。总成交量为7.982千万股，总成交金额为港币$6.461亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608202499/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608202499/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660477197","title":"mRNA領域重大突破！創新藥概念股飆升，雲頂新耀飆升55%，晶泰控股、金斯瑞大升逾12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660477197","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660477197?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:17","pubTimestamp":1787192273,"startTime":"0","endTime":"0","summary":"消息面上，美国制药企业默沙东和莫德纳周三宣布，其实验性信使核糖核酸皮肤癌疫苗在最后阶段临床试验中取得积极结果。专家认为，这是治疗此类癌症的一项“重大突破”。这款名为“intismeran autogene”的新疗法采用mRNA技术。该技术此前已被用于研制新冠疫苗。研究人员多年来一直尝试开发基于mRNA技术的癌症疗法，此次三期临床试验取得积极结果尚属首次。","market":"fut","thumbnail":"http://imgcloud.jrjimg.cn/2026/08/cms_20260820101753777.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/08/cms_20260820101753777.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/08/20101758183255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MEDX","BK1617","LNGR","01952","02228","BK1574","06978","BK1161","IBBQ","BK1141","159992","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162366260","title":"港股創新藥概念股集體走強，中國生物製藥升逾20%，石藥集團升逾16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162366260","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162366260?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:59","pubTimestamp":1787191169,"startTime":"0","endTime":"0","summary":"8月20日，港股创新药概念股集体走强，$中国生物制药(01177)$涨超20%，$石药集团(01093)$涨超16%，$晶泰控股(02228)$、$金斯瑞生物科技(01548)$涨超12%，$乐普生物(02157)$、$康方生物(09926)$涨超11%，$荣昌生物(09995)$、$复星医药(02196)$涨超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1191","LU2399975544.HKD","BK1583","LU0880133367.SGD","LNGR","LU0315179316.USD","LU0417516738.SGD","LU1993786604.SGD","IBBQ","LU0540923850.HKD","LU0561508036.HKD","LU1794554557.SGD","BK1617","BK1521","LU0348827113.USD","LU1226288253.USD","LU2778985437.USD","LU1226287529.USD","LU0326950275.SGD","06978","02196","LU2476274720.SGD","LU2476274308.USD","IE00BZ08YR35.GBP","HK0000306685.HKD","09926","IE00B5MMRT66.SGD","159992","LU1152091168.USD","VXUS","IE00B543WZ88.USD","LU0348783233.USD","LU1152091754.HKD","LU1813983027.USD","LU0348825331.USD","BK1161","HK0000320223.HKD","LU0140636845.USD","LU0348735423.USD","SG9999004220.SGD","LU1951186391.HKD","HK0000306701.USD","IE0008368742.USD","BK1141","IE00BZ08YS42.EUR","09995","LU0501845795.SGD","LU1807302812.USD","KCAI","LU1969619763.USD","BK1574","LU0348784397.USD","BK1515","BK1593","IE0008369823.USD","02228","LU0348766576.USD","LU2039709279.SGD","IE00B031HY20.USD","HK0000165453.HKD","LU1008478684.HKD","LU0417516902.SGD","LU0072913022.USD","01548","KURE","LU0348767384.USD","MEDX","LU0314109678.HKD","01177","LU0417516571.SGD","LU1226287875.USD","LU1328277881.USD","01093","LU1226288170.HKD","BK1589","LU2488822045.USD","IE00BPRC5H50.USD","LU1720050803.USD","LU1960683339.HKD","LU0067412154.USD","LU2328871848.SGD","LU1961090484.USD","BK1576","LU1226287792.SGD","HK0000320264.USD","02157","LU0634319403.HKD","IE00BZ08YT58.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146294369","title":"異動解讀｜晶泰控股盤中上漲9.96%，中期業績剔除高基數後主業增長73.8%獲市場認可","url":"https://stock-news.laohu8.com/highlight/detail?id=1146294369","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146294369?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:31","pubTimestamp":1787189477,"startTime":"0","endTime":"0","summary":"8月20日，晶泰控股盘中上涨9.96%，报7.905港元，成交额1752.51万港元。但剔除去年同期确认的5100万美元大额管线授权首付款高基数影响后，公司核心业务收入同比增长73.8%，AI4S智慧解决方案业务同比增长136.4%。此外，公司披露管线进展积极，已达成潜在总金额超4亿美元的AI药物发现战略合作，叠加同业英矽智能、金斯瑞等板块个股同步走强，市场对其主业高速增长给予正面定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股盘中上涨9.96%，中期业绩剔除高基数后主业增长73.8%获市场认可","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660444997","title":"晶泰控股(02228)發布中期業績 收入3.94億元 研發開支按年增加66.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660444997","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660444997?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 18:17","pubTimestamp":1787134678,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股(02228)发布截至20266月30日止六个月的中期业绩，收入3.94亿元(人民币，下同);研发开支3.68亿元，同比增加66.05%;股东应占亏损2.52亿元;每股基本亏损6分。公告称，收入同比减少主要由于去年同期确认大额管线授权收入，形成较高比较基数。剔除该影响后，公司的收入实现高速增长，同比增长73.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146460810","title":"晶泰控股（02228）發布2026年中報：營收3.94億元，按年降23.9%，研發投入增長66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146460810","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146460810?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 18:16","pubTimestamp":1787134564,"startTime":"0","endTime":"0","summary":"2026年8月19日，晶泰控股有限公司披露截至2026年6月30日止六个月未经审计的中期业绩。期内公司实现收入3.94亿元，同比下降23.9%。公司解释称，上年同期确认一笔5,100万美元的管线授权首付款导致基数较高；若剔除此因素，收入同比增长73.8%。受收入结构变化及研发投入加大影响，期内公司录得经营亏损2.54亿元；净亏损2.25亿元。经调整后，公司净亏损1.06亿元，调整项目包括0.66亿元的股份支付及0.53亿元的可转换债券利息费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125590102","title":"異動解讀｜晶泰控股盤中下跌5.62%，中期業績披露前夕市場搶跑拋壓集中釋放","url":"https://stock-news.laohu8.com/highlight/detail?id=1125590102","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125590102?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 13:15","pubTimestamp":1787030142,"startTime":"0","endTime":"0","summary":"8月18日，晶泰控股盘中下跌5.62%，报7.475港元，成交额2.47亿港元。收入预计3.8亿至4亿元，同比下滑逾22%，主因去年同期确认一项大额管线授权首付款5100万美元形成高基数；同时研发费用不低于3.4亿元，同比增长超50%。业绩窗口临近叠加亏损预期明确，资金提前离场避险。同行业中，英矽智能同日跌7.56%，AI制药板块整体承压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660073001","title":"再獲\"醫藥界諾貝爾獎\"提名！晶泰科技孵化企業萊芒生物、默達生物共同入圍2026蓋倫獎","url":"https://stock-news.laohu8.com/highlight/detail?id=2660073001","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660073001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 12:59","pubTimestamp":1786942740,"startTime":"0","endTime":"0","summary":"晶泰科技孵化企业莱芒生物与默达生物双双入围\"最佳初创公司\" 奖项。这是继 2025 年晶泰孵化企业希格生科获得 \"最佳生物技术产品奖\" 提名后，晶泰生态圈企业连续第二年登上盖伦奖榜单。晶泰科技孵化企业莱芒生物与默达生物双双入围 盖伦奖“最佳初创公司” 奖项  盖伦奖创立于 1970 年，旨在表彰能显著改善人类健康的杰出科学创新，是全球制药和生物医学领域最高荣誉之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5027293_ZH27293_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5027293_ZH27293_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659299118","title":"創新藥概念集體回調 康方生物（09926）跌6.85%、維亞生物（01873）跌6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659299118","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659299118?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 13:51","pubTimestamp":1786686711,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念集体回调，康方生物 跌6.85%，维亚生物跌6.33%，思路迪医药股份跌6.15%，恒瑞医药跌5.10%，晶泰控股跌4.88%，凯莱英跌4.67%，亚盛医药跌4.04%，药明康德跌3.94%，百济神州跌3.92%。西南证券表示，CXO+创新药放量领涨，8-9月有望迎来业绩+临床数据共振。从产业链的角度，CXO板块投融资改善明显，26H1中国/全球医疗健康投融资分别676.47亿元/2416.43亿元，ADC、多肽、细胞基因治疗等新药物形式赛道持续火热，头部CXO公司海外订单复苏明显。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988233","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","KURE","LU1961090484.USD","LU1770034418.SGD","LU0228659784.USD","BK1588","LU0348766576.USD","06821","IE00B543WZ88.USD","LU0634319403.HKD","LU0561508036.HKD","09926","IE00B5MMRT66.SGD","02228","LU0327786744.USD","LU2045819591.USD","MEDX","LU0588546209.SGD","LU2476274308.USD","LU0359202008.SGD","LU0572944931.SGD","LU0348827113.USD","06855","BK1574","LU0348784397.USD","01276","LU0052750758.USD","LU0828237510.HKD","LU0348783233.USD","LU2476274720.SGD","LU2399975544.HKD","06160","LU0307460666.USD","LU1720050803.USD","06978","IBBQ","BK1617","LU1719994722.HKD","LU2778985437.USD","LU2242644610.SGD","BK1576","BK1141","LU1794554557.SGD","LU0708995583.HKD","01873","02359","159992","01244","LU1251922891.USD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184084820","title":"異動解讀｜晶泰控股盤中下跌5.01%，板塊集體回調疊加業績窗口期承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=1184084820","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184084820?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 13:20","pubTimestamp":1786684803,"startTime":"0","endTime":"0","summary":"8月14日，晶泰控股盘中下跌5.01%，报7.78港元，成交额2.5亿港元。消息面上，生命科学工具和服务板块今日集体走弱，金斯瑞生物科技跌5.93%、英矽智能跌5.52%、药明康德跌3.4%、药明合联跌3.16%，AI制药赛道资金回落明显。此前公司连续多日强势上涨（8月10日至11日累计涨幅超13%），短期获利盘集中涌出。同时，公司8月19日即将披露中期业绩，此前已预告上半年由盈转亏、净亏损约2.15亿至2.75亿元人民币，业绩窗口期临近加剧市场谨慎情绪。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659183661","title":"晶泰控股(02228)股價下跌5.006%，現價港幣$7.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2659183661","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659183661?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 13:18","pubTimestamp":1786684680,"startTime":"0","endTime":"0","summary":"[下跌股]晶泰控股(02228) 股价在下午01:18比前收市价下跌5.006%，现股价为港币$7.78。至目前为止，今日最高价为$8.2，而最低价为$7.78。总成交量为3.128千万股，总成交金额为港币$2.494亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608142073/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608142073/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659199950","title":"【券商聚焦】中信建投：AI製藥大有可為，產業鏈有望持續受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2659199950","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659199950?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 08:58","pubTimestamp":1786669118,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指出，AI制药领域正经历着快速的迭代和变革，算法的更新迭代和算力的支持为AI在制药领域的应用打下了良好的基础。传统药物开发过程花费时间长成本高，且成功率较低，随着已有靶点的新药陆续获批，新药开发难度逐渐上升。近年来AI特别是深度学习的发展，促进了其在包括靶点筛选、分子生成及优化、ADMET预测、晶型预测以及合成路线筛选等的应用，AI用于大分子药物的开发投入也持续增长。AIDD有望重塑早期药物发现的流程，大大加速早期药物筛选的效率及成功率，相关干实验投入的增加以及对湿实验需求持续的增长，有望为下游产业链持续带来增量。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988188","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","02367","IE00B5MMRT66.SGD","LU0348735423.USD","02268","LU2778985437.USD","SG9999004311.SGD","AIPO","LU0561508036.HKD","VTHR","LU0348825331.USD","BK1191","LU0417516571.SGD","LU0640798160.USD","601066","BK1197","LU1303224171.USD","LU1719994722.HKD","LU2328871848.SGD","09688","06821","02228","AGIX","LU1961090484.USD","LU2476274720.SGD","LU0634319403.HKD","01789","03933","LU0417516738.SGD","LU1770034418.SGD","LU0540923850.HKD","LU0828237510.HKD","02196","LU0348827113.USD","06160","09926","01530","BK1500","BK1585","LU0348783233.USD","01099","CHAT","LU2476274308.USD","01477","KCE","LU0348766576.USD","QTOC","LU0348784397.USD","ARTY","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167909731","title":"財報前瞻｜晶泰控股本季度營收暫無一致預測，機構觀點尚不明確","url":"https://stock-news.laohu8.com/highlight/detail?id=1167909731","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167909731?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 08:40","pubTimestamp":1786495217,"startTime":"0","endTime":"0","summary":"晶泰控股将于2026年08月19日披露最新季度财报，本文围绕市场预测、上季度回顾及本季度展望进行梳理。由于公开渠道尚未形成一致预期，当前未获取到对本季度营收、毛利率、净利润或净利率、调整后每股收益的量化预测；公司上季度财报文本中关于本季度的具体指引亦未检索到有效数据。近期主流机构对晶泰控股的季度前瞻观点尚未形成明确多数派结论，未检索到足以统计看多或看空比例的分析师报告，因而难以界定市场的偏向性观点。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜晶泰控股本季度营收暂无一致预测，机构观点尚不明确","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2658369969","title":"創新藥概念繼續走強 金斯瑞生物科技（01548）漲6.87% 機構指中國創新藥全球地位持續提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658369969","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658369969?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:15","pubTimestamp":1786418137,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念持续走强，截至发稿，金斯瑞生物科技 涨6.87%，再鼎医药涨5.51%，同源康医药-B涨4.81%，晶泰控股涨3.94%，药明合联涨3.92%，翰森制药涨3.76%，亚盛医药涨3.63%，百济神州涨3.38%，药明康德涨3.03%，诺诚健华涨2.83%，石药集团涨2.78%。国元国际证券亦表示，出海交易量价齐升，中国创新药全球地位持续提升。中国创新药出海持续超预期，上半年997亿美元的交易总额和全球TOP10中独占8席的成绩，充分验证了中国创新药资产的全球竞争力。","market":"other","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987912","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","LU1993786604.SGD","06855","LU1813983027.USD","MEDX","09688","HK0000306685.HKD","HK0000320223.HKD","IE00BZ08YT58.USD","01093","KURE","LU1152091168.USD","LU2039709279.SGD","BK1583","LU2328871848.SGD","LU0072913022.USD","09969","LU0315179316.USD","02228","IE00BZ08YR35.GBP","02268","LU1226287792.SGD","159992","LNGR","BK1500","LU1951186391.HKD","BK1521","IE00B031HY20.USD","LU1226288170.HKD","LU2125910500.SGD","LU2242644610.SGD","LU0326950275.SGD","02359","LU1303224171.USD","IE00B5MMRT66.SGD","03692","01548","BK1617","LU1226287875.USD","LU2488822045.USD","06160","BK1515","IBBQ","06978","02410","IE00B543WZ88.USD","IE00BZ08YS42.EUR","BK1161","BK1576","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198305012","title":"異動解讀 | 晶泰控股盤中大漲5.04%，AI平台發布及大行唱好持續催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1198305012","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198305012?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 09:38","pubTimestamp":1786412305,"startTime":"0","endTime":"0","summary":"晶泰控股（02228）今日盘中股价大幅拉升，一度涨超5%，延续近期的强势表现，引发市场广泛关注。消息面上，公司近日正式发布XtalPi Science科学智能平台，并联合26家机构发起“科学智能开放生态联盟”，市场对其估值逻辑由CRO服务商向AI平台型公司切换的预期持续升温。同时，摩根大通首次给予公司“增持”评级，浙商证券维持“买入”评级，并指出剔除一次性管线影响后主业同比增长65%，机构看多共识进一步巩固。此外，公司将于近期召开董事会审议中期业绩，业绩窗口期临近亦吸引资金关注。板块层面，生命科学工具和服务行业今日整体走强，AI制药赛道资金共振对公司股价形成正向带动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":185,"code":"91000000","status":"200"}]}}